Global In Vitro Transcription RNA Synthesis Service Supply, Demand and Key Producers, 2026-2032
The global In Vitro Transcription RNA Synthesis Service market size is expected to reach $ 2282 million by 2032, rising at a market growth of 10.9% CAGR during the forecast period (2026-2032).
In vitro transcription RNA synthesis services are customized technical services in which providers use T7, SP6 or other RNA polymerases in cell-free systems to manufacture RNA according to customer-supplied sequences, DNA templates or therapeutic-development requirements. Services may include sequence and codon optimization, UTR design, plasmid or linear DNA template preparation, 5' capping, 3' poly(A) tail generation, modified nucleotide incorporation, nuclease treatment, chromatographic or membrane purification, formulation and quality testing. Major deliverables include linear mRNA, self-amplifying RNA, circular RNA and other functional long RNAs. Key upstream inputs include plasmid or linear DNA templates, natural and modified nucleoside triphosphates, T7 or SP6 RNA polymerases, capping enzymes, poly(A) polymerase, DNase, phosphatases, cap analogs, buffers, chromatography media, affinity resins, ultrafiltration membranes, single-use reaction assemblies, sterile filters and low-binding containers. Major downstream customers include pharmaceutical companies, biotechnology companies, vaccine developers, gene-editing and cell-therapy companies, diagnostic developers, universities, research institutes and contract research organizations. The industry's overall gross margin was approximately 35%?55%.
The global in vitro transcription RNA synthesis service market is characterized by the participation of large integrated CDMOs, specialist RNA technology companies and high-throughput research-service providers. Large CDMOs primarily support process development, clinical-grade drug substance and commercial manufacturing, frequently combining DNA template production, IVT, purification, analytical development, GMP release and regulatory support. Specialist RNA companies compete through proprietary capping technologies, modified nucleotides, complex RNA formats and rapid small-batch delivery. The research-grade segment has a relatively large number of providers and stronger competition on price and turnaround time, while clinical-grade supply is more concentrated because of quality-system, facility, analytical and regulatory requirements.
Future demand will be driven by a broader range of RNA programs beyond vaccines, including cancer immunotherapy, protein replacement, rare-disease treatment, gene editing, cell therapy and personalized medicines. Compared with recombinant proteins or viral vectors, IVT RNA manufacturing is highly sequence-flexible and generally does not require the establishment of a new production cell line for every candidate. This makes the platform suitable for rapid screening, parallel candidate development and personalized manufacturing. A growing number of biotechnology companies are expected to outsource both early sequence screening and clinical manufacturing to reduce capital investment in dedicated facilities, process-development teams and analytical platforms.
Technology development will focus on higher full-length RNA content, lower double-stranded RNA impurities, improved capping efficiency, more uniform poly(A) tails and more robust scale-up. Co-transcriptional capping, engineered RNA polymerases, cell-free DNA templates, selective affinity purification and continuous membrane processing are expected to improve production efficiency. Self-amplifying and circular RNA may reduce dose requirements or extend protein expression, but their greater length, structural heterogeneity and purification complexity require dedicated processes and analytical methods. Artificial intelligence-based sequence optimization, UTR screening and manufacturability prediction will also become more widely incorporated into project design.
The industry continues to face constraints associated with project-demand volatility, evolving quality standards, critical raw-material supply and limited availability of advanced analytical methods. Clinical-grade projects require control of residual DNA, double-stranded RNA, truncated transcripts, uncapped RNA, enzyme proteins and endotoxins, together with potency assays aligned with the product's mechanism of action. Processes cannot be fully standardized across different RNA lengths, modifications and capping methods, making technology transfer and scale-up highly project-specific. As some capacity built during the pandemic enters routine use, commodity production may experience pricing pressure, while providers with complex-RNA expertise, GMP manufacturing, comprehensive analytics and regulatory support are expected to secure more stable demand.
This report studies the global In Vitro Transcription RNA Synthesis Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for In Vitro Transcription RNA Synthesis Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of In Vitro Transcription RNA Synthesis Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global In Vitro Transcription RNA Synthesis Service total market, 2021-2032, (USD Million)
Global In Vitro Transcription RNA Synthesis Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: In Vitro Transcription RNA Synthesis Service total market, key domestic companies, and share, (USD Million)
Global In Vitro Transcription RNA Synthesis Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global In Vitro Transcription RNA Synthesis Service total market by Type, CAGR, 2021-2032, (USD Million)
Global In Vitro Transcription RNA Synthesis Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global In Vitro Transcription RNA Synthesis Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Maravai LifeSciences, Danaher, Thermo Fisher Scientific, Lonza, Merck KGaA, AGC, Kaneka, Curia, Biomay, GenScript Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world In Vitro Transcription RNA Synthesis Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global In Vitro Transcription RNA Synthesis Service Market, By Region:
1. How big is the global In Vitro Transcription RNA Synthesis Service market?
2. What is the demand of the global In Vitro Transcription RNA Synthesis Service market?
3. What is the year over year growth of the global In Vitro Transcription RNA Synthesis Service market?
4. What is the total value of the global In Vitro Transcription RNA Synthesis Service market?
5. Who are the Major Players in the global In Vitro Transcription RNA Synthesis Service market?
6. What are the growth factors driving the market demand?
In vitro transcription RNA synthesis services are customized technical services in which providers use T7, SP6 or other RNA polymerases in cell-free systems to manufacture RNA according to customer-supplied sequences, DNA templates or therapeutic-development requirements. Services may include sequence and codon optimization, UTR design, plasmid or linear DNA template preparation, 5' capping, 3' poly(A) tail generation, modified nucleotide incorporation, nuclease treatment, chromatographic or membrane purification, formulation and quality testing. Major deliverables include linear mRNA, self-amplifying RNA, circular RNA and other functional long RNAs. Key upstream inputs include plasmid or linear DNA templates, natural and modified nucleoside triphosphates, T7 or SP6 RNA polymerases, capping enzymes, poly(A) polymerase, DNase, phosphatases, cap analogs, buffers, chromatography media, affinity resins, ultrafiltration membranes, single-use reaction assemblies, sterile filters and low-binding containers. Major downstream customers include pharmaceutical companies, biotechnology companies, vaccine developers, gene-editing and cell-therapy companies, diagnostic developers, universities, research institutes and contract research organizations. The industry's overall gross margin was approximately 35%?55%.
The global in vitro transcription RNA synthesis service market is characterized by the participation of large integrated CDMOs, specialist RNA technology companies and high-throughput research-service providers. Large CDMOs primarily support process development, clinical-grade drug substance and commercial manufacturing, frequently combining DNA template production, IVT, purification, analytical development, GMP release and regulatory support. Specialist RNA companies compete through proprietary capping technologies, modified nucleotides, complex RNA formats and rapid small-batch delivery. The research-grade segment has a relatively large number of providers and stronger competition on price and turnaround time, while clinical-grade supply is more concentrated because of quality-system, facility, analytical and regulatory requirements.
Future demand will be driven by a broader range of RNA programs beyond vaccines, including cancer immunotherapy, protein replacement, rare-disease treatment, gene editing, cell therapy and personalized medicines. Compared with recombinant proteins or viral vectors, IVT RNA manufacturing is highly sequence-flexible and generally does not require the establishment of a new production cell line for every candidate. This makes the platform suitable for rapid screening, parallel candidate development and personalized manufacturing. A growing number of biotechnology companies are expected to outsource both early sequence screening and clinical manufacturing to reduce capital investment in dedicated facilities, process-development teams and analytical platforms.
Technology development will focus on higher full-length RNA content, lower double-stranded RNA impurities, improved capping efficiency, more uniform poly(A) tails and more robust scale-up. Co-transcriptional capping, engineered RNA polymerases, cell-free DNA templates, selective affinity purification and continuous membrane processing are expected to improve production efficiency. Self-amplifying and circular RNA may reduce dose requirements or extend protein expression, but their greater length, structural heterogeneity and purification complexity require dedicated processes and analytical methods. Artificial intelligence-based sequence optimization, UTR screening and manufacturability prediction will also become more widely incorporated into project design.
The industry continues to face constraints associated with project-demand volatility, evolving quality standards, critical raw-material supply and limited availability of advanced analytical methods. Clinical-grade projects require control of residual DNA, double-stranded RNA, truncated transcripts, uncapped RNA, enzyme proteins and endotoxins, together with potency assays aligned with the product's mechanism of action. Processes cannot be fully standardized across different RNA lengths, modifications and capping methods, making technology transfer and scale-up highly project-specific. As some capacity built during the pandemic enters routine use, commodity production may experience pricing pressure, while providers with complex-RNA expertise, GMP manufacturing, comprehensive analytics and regulatory support are expected to secure more stable demand.
This report studies the global In Vitro Transcription RNA Synthesis Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for In Vitro Transcription RNA Synthesis Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of In Vitro Transcription RNA Synthesis Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global In Vitro Transcription RNA Synthesis Service total market, 2021-2032, (USD Million)
Global In Vitro Transcription RNA Synthesis Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: In Vitro Transcription RNA Synthesis Service total market, key domestic companies, and share, (USD Million)
Global In Vitro Transcription RNA Synthesis Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global In Vitro Transcription RNA Synthesis Service total market by Type, CAGR, 2021-2032, (USD Million)
Global In Vitro Transcription RNA Synthesis Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global In Vitro Transcription RNA Synthesis Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Maravai LifeSciences, Danaher, Thermo Fisher Scientific, Lonza, Merck KGaA, AGC, Kaneka, Curia, Biomay, GenScript Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world In Vitro Transcription RNA Synthesis Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global In Vitro Transcription RNA Synthesis Service Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Linear mRNA
- Self-amplifying RNA
- Circular RNA
- Other
- Research Grade
- GMP Grade
- Other
- Up to 1,000 nt
- Above 1,000 nt to 5,000 nt
- Above 5,000 nt to 10,000 nt
- Above 10,000 nt
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Other
- Maravai LifeSciences
- Danaher
- Thermo Fisher Scientific
- Lonza
- Merck KGaA
- AGC
- Kaneka
- Curia
- Biomay
- GenScript Biotech
- Hongene Biotech
- VectorBuilder
1. How big is the global In Vitro Transcription RNA Synthesis Service market?
2. What is the demand of the global In Vitro Transcription RNA Synthesis Service market?
3. What is the year over year growth of the global In Vitro Transcription RNA Synthesis Service market?
4. What is the total value of the global In Vitro Transcription RNA Synthesis Service market?
5. Who are the Major Players in the global In Vitro Transcription RNA Synthesis Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 In Vitro Transcription RNA Synthesis Service Introduction
1.2 World In Vitro Transcription RNA Synthesis Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World In Vitro Transcription RNA Synthesis Service Total Market by Region (by Headquarter Location)
1.3.1 World In Vitro Transcription RNA Synthesis Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032)
1.3.3 China Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032)
1.3.4 Europe Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032)
1.3.5 Japan Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032)
1.3.6 South Korea Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032)
1.3.7 ASEAN Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032)
1.3.8 India Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 In Vitro Transcription RNA Synthesis Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032)
2.2 World In Vitro Transcription RNA Synthesis Service Consumption Value by Region
2.2.1 World In Vitro Transcription RNA Synthesis Service Consumption Value by Region (2021-2026)
2.2.2 World In Vitro Transcription RNA Synthesis Service Consumption Value Forecast by Region (2027-2032)
2.3 United States In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032)
2.4 China In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032)
2.5 Europe In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032)
2.6 Japan In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032)
2.7 South Korea In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032)
2.8 ASEAN In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032)
2.9 India In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032)
3 WORLD IN VITRO TRANSCRIPTION RNA SYNTHESIS SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World In Vitro Transcription RNA Synthesis Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global In Vitro Transcription RNA Synthesis Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for In Vitro Transcription RNA Synthesis Service in 2025
3.2.3 Global Concentration Ratios (CR8) for In Vitro Transcription RNA Synthesis Service in 2025
3.3 In Vitro Transcription RNA Synthesis Service Company Evaluation Quadrant
3.4 In Vitro Transcription RNA Synthesis Service Market: Overall Company Footprint Analysis
3.4.1 In Vitro Transcription RNA Synthesis Service Market: Region Footprint
3.4.2 In Vitro Transcription RNA Synthesis Service Market: Company Product Type Footprint
3.4.3 In Vitro Transcription RNA Synthesis Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: In Vitro Transcription RNA Synthesis Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: In Vitro Transcription RNA Synthesis Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: In Vitro Transcription RNA Synthesis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: In Vitro Transcription RNA Synthesis Service Consumption Value Comparison
4.2.1 United States VS China: In Vitro Transcription RNA Synthesis Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: In Vitro Transcription RNA Synthesis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based In Vitro Transcription RNA Synthesis Service Companies and Market Share, 2021-2026
4.3.1 United States Based In Vitro Transcription RNA Synthesis Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies In Vitro Transcription RNA Synthesis Service Revenue, (2021-2026)
4.4 China Based Companies In Vitro Transcription RNA Synthesis Service Revenue and Market Share, 2021-2026
4.4.1 China Based In Vitro Transcription RNA Synthesis Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies In Vitro Transcription RNA Synthesis Service Revenue, (2021-2026)
4.5 Rest of World Based In Vitro Transcription RNA Synthesis Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based In Vitro Transcription RNA Synthesis Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies In Vitro Transcription RNA Synthesis Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World In Vitro Transcription RNA Synthesis Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Linear mRNA
5.2.2 Self-amplifying RNA
5.2.3 Circular RNA
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World In Vitro Transcription RNA Synthesis Service Market Size by Type (2021-2026)
5.3.2 World In Vitro Transcription RNA Synthesis Service Market Size by Type (2027-2032)
5.3.3 World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY QUALITY GRADE
6.1 World In Vitro Transcription RNA Synthesis Service Market Size Overview by Quality Grade: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Quality Grade
6.2.1 Research Grade
6.2.2 GMP Grade
6.2.3 Other
6.3 Market Segment by Quality Grade
6.3.1 World In Vitro Transcription RNA Synthesis Service Market Size by Quality Grade (2021-2026)
6.3.2 World In Vitro Transcription RNA Synthesis Service Market Size by Quality Grade (2027-2032)
6.3.3 World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Quality Grade (2027-2032)
7 MARKET ANALYSIS BY RNA LENGTH
7.1 World In Vitro Transcription RNA Synthesis Service Market Size Overview by RNA Length: 2021 VS 2025 VS 2032
7.2 Segment Introduction by RNA Length
7.2.1 Up to 1,000 nt
7.2.2 Above 1,000 nt to 5,000 nt
7.2.3 Above 5,000 nt to 10,000 nt
7.2.4 Above 10,000 nt
7.3 Market Segment by RNA Length
7.3.1 World In Vitro Transcription RNA Synthesis Service Market Size by RNA Length (2021-2026)
7.3.2 World In Vitro Transcription RNA Synthesis Service Market Size by RNA Length (2027-2032)
7.3.3 World In Vitro Transcription RNA Synthesis Service Market Size Market Share by RNA Length (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World In Vitro Transcription RNA Synthesis Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical and Biotechnology Companies
8.2.2 Academic and Research Institutes
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World In Vitro Transcription RNA Synthesis Service Market Size by Application (2021-2026)
8.3.2 World In Vitro Transcription RNA Synthesis Service Market Size by Application (2027-2032)
8.3.3 World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Maravai LifeSciences
9.1.1 Maravai LifeSciences Details
9.1.2 Maravai LifeSciences Major Business
9.1.3 Maravai LifeSciences In Vitro Transcription RNA Synthesis Service Product and Services
9.1.4 Maravai LifeSciences In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Maravai LifeSciences Recent Developments/Updates
9.1.6 Maravai LifeSciences Competitive Strengths & Weaknesses
9.2 Danaher
9.2.1 Danaher Details
9.2.2 Danaher Major Business
9.2.3 Danaher In Vitro Transcription RNA Synthesis Service Product and Services
9.2.4 Danaher In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Danaher Recent Developments/Updates
9.2.6 Danaher Competitive Strengths & Weaknesses
9.3 Thermo Fisher Scientific
9.3.1 Thermo Fisher Scientific Details
9.3.2 Thermo Fisher Scientific Major Business
9.3.3 Thermo Fisher Scientific In Vitro Transcription RNA Synthesis Service Product and Services
9.3.4 Thermo Fisher Scientific In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Thermo Fisher Scientific Recent Developments/Updates
9.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.4 Lonza
9.4.1 Lonza Details
9.4.2 Lonza Major Business
9.4.3 Lonza In Vitro Transcription RNA Synthesis Service Product and Services
9.4.4 Lonza In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Lonza Recent Developments/Updates
9.4.6 Lonza Competitive Strengths & Weaknesses
9.5 Merck KGaA
9.5.1 Merck KGaA Details
9.5.2 Merck KGaA Major Business
9.5.3 Merck KGaA In Vitro Transcription RNA Synthesis Service Product and Services
9.5.4 Merck KGaA In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Merck KGaA Recent Developments/Updates
9.5.6 Merck KGaA Competitive Strengths & Weaknesses
9.6 AGC
9.6.1 AGC Details
9.6.2 AGC Major Business
9.6.3 AGC In Vitro Transcription RNA Synthesis Service Product and Services
9.6.4 AGC In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 AGC Recent Developments/Updates
9.6.6 AGC Competitive Strengths & Weaknesses
9.7 Kaneka
9.7.1 Kaneka Details
9.7.2 Kaneka Major Business
9.7.3 Kaneka In Vitro Transcription RNA Synthesis Service Product and Services
9.7.4 Kaneka In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Kaneka Recent Developments/Updates
9.7.6 Kaneka Competitive Strengths & Weaknesses
9.8 Curia
9.8.1 Curia Details
9.8.2 Curia Major Business
9.8.3 Curia In Vitro Transcription RNA Synthesis Service Product and Services
9.8.4 Curia In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Curia Recent Developments/Updates
9.8.6 Curia Competitive Strengths & Weaknesses
9.9 Biomay
9.9.1 Biomay Details
9.9.2 Biomay Major Business
9.9.3 Biomay In Vitro Transcription RNA Synthesis Service Product and Services
9.9.4 Biomay In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Biomay Recent Developments/Updates
9.9.6 Biomay Competitive Strengths & Weaknesses
9.10 GenScript Biotech
9.10.1 GenScript Biotech Details
9.10.2 GenScript Biotech Major Business
9.10.3 GenScript Biotech In Vitro Transcription RNA Synthesis Service Product and Services
9.10.4 GenScript Biotech In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 GenScript Biotech Recent Developments/Updates
9.10.6 GenScript Biotech Competitive Strengths & Weaknesses
9.11 Hongene Biotech
9.11.1 Hongene Biotech Details
9.11.2 Hongene Biotech Major Business
9.11.3 Hongene Biotech In Vitro Transcription RNA Synthesis Service Product and Services
9.11.4 Hongene Biotech In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Hongene Biotech Recent Developments/Updates
9.11.6 Hongene Biotech Competitive Strengths & Weaknesses
9.12 VectorBuilder
9.12.1 VectorBuilder Details
9.12.2 VectorBuilder Major Business
9.12.3 VectorBuilder In Vitro Transcription RNA Synthesis Service Product and Services
9.12.4 VectorBuilder In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 VectorBuilder Recent Developments/Updates
9.12.6 VectorBuilder Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 In Vitro Transcription RNA Synthesis Service Industry Chain
10.2 In Vitro Transcription RNA Synthesis Service Upstream Analysis
10.3 In Vitro Transcription RNA Synthesis Service Midstream Analysis
10.4 In Vitro Transcription RNA Synthesis Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 In Vitro Transcription RNA Synthesis Service Introduction
1.2 World In Vitro Transcription RNA Synthesis Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World In Vitro Transcription RNA Synthesis Service Total Market by Region (by Headquarter Location)
1.3.1 World In Vitro Transcription RNA Synthesis Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032)
1.3.3 China Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032)
1.3.4 Europe Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032)
1.3.5 Japan Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032)
1.3.6 South Korea Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032)
1.3.7 ASEAN Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032)
1.3.8 India Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 In Vitro Transcription RNA Synthesis Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032)
2.2 World In Vitro Transcription RNA Synthesis Service Consumption Value by Region
2.2.1 World In Vitro Transcription RNA Synthesis Service Consumption Value by Region (2021-2026)
2.2.2 World In Vitro Transcription RNA Synthesis Service Consumption Value Forecast by Region (2027-2032)
2.3 United States In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032)
2.4 China In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032)
2.5 Europe In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032)
2.6 Japan In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032)
2.7 South Korea In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032)
2.8 ASEAN In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032)
2.9 India In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032)
3 WORLD IN VITRO TRANSCRIPTION RNA SYNTHESIS SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World In Vitro Transcription RNA Synthesis Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global In Vitro Transcription RNA Synthesis Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for In Vitro Transcription RNA Synthesis Service in 2025
3.2.3 Global Concentration Ratios (CR8) for In Vitro Transcription RNA Synthesis Service in 2025
3.3 In Vitro Transcription RNA Synthesis Service Company Evaluation Quadrant
3.4 In Vitro Transcription RNA Synthesis Service Market: Overall Company Footprint Analysis
3.4.1 In Vitro Transcription RNA Synthesis Service Market: Region Footprint
3.4.2 In Vitro Transcription RNA Synthesis Service Market: Company Product Type Footprint
3.4.3 In Vitro Transcription RNA Synthesis Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: In Vitro Transcription RNA Synthesis Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: In Vitro Transcription RNA Synthesis Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: In Vitro Transcription RNA Synthesis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: In Vitro Transcription RNA Synthesis Service Consumption Value Comparison
4.2.1 United States VS China: In Vitro Transcription RNA Synthesis Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: In Vitro Transcription RNA Synthesis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based In Vitro Transcription RNA Synthesis Service Companies and Market Share, 2021-2026
4.3.1 United States Based In Vitro Transcription RNA Synthesis Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies In Vitro Transcription RNA Synthesis Service Revenue, (2021-2026)
4.4 China Based Companies In Vitro Transcription RNA Synthesis Service Revenue and Market Share, 2021-2026
4.4.1 China Based In Vitro Transcription RNA Synthesis Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies In Vitro Transcription RNA Synthesis Service Revenue, (2021-2026)
4.5 Rest of World Based In Vitro Transcription RNA Synthesis Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based In Vitro Transcription RNA Synthesis Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies In Vitro Transcription RNA Synthesis Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World In Vitro Transcription RNA Synthesis Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Linear mRNA
5.2.2 Self-amplifying RNA
5.2.3 Circular RNA
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World In Vitro Transcription RNA Synthesis Service Market Size by Type (2021-2026)
5.3.2 World In Vitro Transcription RNA Synthesis Service Market Size by Type (2027-2032)
5.3.3 World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY QUALITY GRADE
6.1 World In Vitro Transcription RNA Synthesis Service Market Size Overview by Quality Grade: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Quality Grade
6.2.1 Research Grade
6.2.2 GMP Grade
6.2.3 Other
6.3 Market Segment by Quality Grade
6.3.1 World In Vitro Transcription RNA Synthesis Service Market Size by Quality Grade (2021-2026)
6.3.2 World In Vitro Transcription RNA Synthesis Service Market Size by Quality Grade (2027-2032)
6.3.3 World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Quality Grade (2027-2032)
7 MARKET ANALYSIS BY RNA LENGTH
7.1 World In Vitro Transcription RNA Synthesis Service Market Size Overview by RNA Length: 2021 VS 2025 VS 2032
7.2 Segment Introduction by RNA Length
7.2.1 Up to 1,000 nt
7.2.2 Above 1,000 nt to 5,000 nt
7.2.3 Above 5,000 nt to 10,000 nt
7.2.4 Above 10,000 nt
7.3 Market Segment by RNA Length
7.3.1 World In Vitro Transcription RNA Synthesis Service Market Size by RNA Length (2021-2026)
7.3.2 World In Vitro Transcription RNA Synthesis Service Market Size by RNA Length (2027-2032)
7.3.3 World In Vitro Transcription RNA Synthesis Service Market Size Market Share by RNA Length (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World In Vitro Transcription RNA Synthesis Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical and Biotechnology Companies
8.2.2 Academic and Research Institutes
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World In Vitro Transcription RNA Synthesis Service Market Size by Application (2021-2026)
8.3.2 World In Vitro Transcription RNA Synthesis Service Market Size by Application (2027-2032)
8.3.3 World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Maravai LifeSciences
9.1.1 Maravai LifeSciences Details
9.1.2 Maravai LifeSciences Major Business
9.1.3 Maravai LifeSciences In Vitro Transcription RNA Synthesis Service Product and Services
9.1.4 Maravai LifeSciences In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Maravai LifeSciences Recent Developments/Updates
9.1.6 Maravai LifeSciences Competitive Strengths & Weaknesses
9.2 Danaher
9.2.1 Danaher Details
9.2.2 Danaher Major Business
9.2.3 Danaher In Vitro Transcription RNA Synthesis Service Product and Services
9.2.4 Danaher In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Danaher Recent Developments/Updates
9.2.6 Danaher Competitive Strengths & Weaknesses
9.3 Thermo Fisher Scientific
9.3.1 Thermo Fisher Scientific Details
9.3.2 Thermo Fisher Scientific Major Business
9.3.3 Thermo Fisher Scientific In Vitro Transcription RNA Synthesis Service Product and Services
9.3.4 Thermo Fisher Scientific In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Thermo Fisher Scientific Recent Developments/Updates
9.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.4 Lonza
9.4.1 Lonza Details
9.4.2 Lonza Major Business
9.4.3 Lonza In Vitro Transcription RNA Synthesis Service Product and Services
9.4.4 Lonza In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Lonza Recent Developments/Updates
9.4.6 Lonza Competitive Strengths & Weaknesses
9.5 Merck KGaA
9.5.1 Merck KGaA Details
9.5.2 Merck KGaA Major Business
9.5.3 Merck KGaA In Vitro Transcription RNA Synthesis Service Product and Services
9.5.4 Merck KGaA In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Merck KGaA Recent Developments/Updates
9.5.6 Merck KGaA Competitive Strengths & Weaknesses
9.6 AGC
9.6.1 AGC Details
9.6.2 AGC Major Business
9.6.3 AGC In Vitro Transcription RNA Synthesis Service Product and Services
9.6.4 AGC In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 AGC Recent Developments/Updates
9.6.6 AGC Competitive Strengths & Weaknesses
9.7 Kaneka
9.7.1 Kaneka Details
9.7.2 Kaneka Major Business
9.7.3 Kaneka In Vitro Transcription RNA Synthesis Service Product and Services
9.7.4 Kaneka In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Kaneka Recent Developments/Updates
9.7.6 Kaneka Competitive Strengths & Weaknesses
9.8 Curia
9.8.1 Curia Details
9.8.2 Curia Major Business
9.8.3 Curia In Vitro Transcription RNA Synthesis Service Product and Services
9.8.4 Curia In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Curia Recent Developments/Updates
9.8.6 Curia Competitive Strengths & Weaknesses
9.9 Biomay
9.9.1 Biomay Details
9.9.2 Biomay Major Business
9.9.3 Biomay In Vitro Transcription RNA Synthesis Service Product and Services
9.9.4 Biomay In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Biomay Recent Developments/Updates
9.9.6 Biomay Competitive Strengths & Weaknesses
9.10 GenScript Biotech
9.10.1 GenScript Biotech Details
9.10.2 GenScript Biotech Major Business
9.10.3 GenScript Biotech In Vitro Transcription RNA Synthesis Service Product and Services
9.10.4 GenScript Biotech In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 GenScript Biotech Recent Developments/Updates
9.10.6 GenScript Biotech Competitive Strengths & Weaknesses
9.11 Hongene Biotech
9.11.1 Hongene Biotech Details
9.11.2 Hongene Biotech Major Business
9.11.3 Hongene Biotech In Vitro Transcription RNA Synthesis Service Product and Services
9.11.4 Hongene Biotech In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Hongene Biotech Recent Developments/Updates
9.11.6 Hongene Biotech Competitive Strengths & Weaknesses
9.12 VectorBuilder
9.12.1 VectorBuilder Details
9.12.2 VectorBuilder Major Business
9.12.3 VectorBuilder In Vitro Transcription RNA Synthesis Service Product and Services
9.12.4 VectorBuilder In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 VectorBuilder Recent Developments/Updates
9.12.6 VectorBuilder Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 In Vitro Transcription RNA Synthesis Service Industry Chain
10.2 In Vitro Transcription RNA Synthesis Service Upstream Analysis
10.3 In Vitro Transcription RNA Synthesis Service Midstream Analysis
10.4 In Vitro Transcription RNA Synthesis Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World In Vitro Transcription RNA Synthesis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World In Vitro Transcription RNA Synthesis Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World In Vitro Transcription RNA Synthesis Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World In Vitro Transcription RNA Synthesis Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World In Vitro Transcription RNA Synthesis Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World In Vitro Transcription RNA Synthesis Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World In Vitro Transcription RNA Synthesis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World In Vitro Transcription RNA Synthesis Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World In Vitro Transcription RNA Synthesis Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key In Vitro Transcription RNA Synthesis Service Players in 2025
Table 12. World In Vitro Transcription RNA Synthesis Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global In Vitro Transcription RNA Synthesis Service Company Evaluation Quadrant
Table 14. Head Office of Key In Vitro Transcription RNA Synthesis Service Players
Table 15. In Vitro Transcription RNA Synthesis Service Market: Company Product Type Footprint
Table 16. In Vitro Transcription RNA Synthesis Service Market: Company Product Application Footprint
Table 17. In Vitro Transcription RNA Synthesis Service Mergers & Acquisitions Activity
Table 18. United States VS China In Vitro Transcription RNA Synthesis Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China In Vitro Transcription RNA Synthesis Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based In Vitro Transcription RNA Synthesis Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies In Vitro Transcription RNA Synthesis Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies In Vitro Transcription RNA Synthesis Service Revenue Market Share (2021-2026)
Table 23. China Based In Vitro Transcription RNA Synthesis Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies In Vitro Transcription RNA Synthesis Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies In Vitro Transcription RNA Synthesis Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based In Vitro Transcription RNA Synthesis Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies In Vitro Transcription RNA Synthesis Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies In Vitro Transcription RNA Synthesis Service Revenue Market Share (2021-2026)
Table 29. World In Vitro Transcription RNA Synthesis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World In Vitro Transcription RNA Synthesis Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World In Vitro Transcription RNA Synthesis Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World In Vitro Transcription RNA Synthesis Service Market Size by Quality Grade, (USD Million), 2021 & 2025 & 2032
Table 33. World In Vitro Transcription RNA Synthesis Service Market Size Value by Quality Grade (2021-2026) & (USD Million)
Table 34. World In Vitro Transcription RNA Synthesis Service Market Size by Quality Grade (2027-2032) & (USD Million)
Table 35. World In Vitro Transcription RNA Synthesis Service Market Size by RNA Length, (USD Million), 2021 & 2025 & 2032
Table 36. World In Vitro Transcription RNA Synthesis Service Market Size Value by RNA Length (2021-2026) & (USD Million)
Table 37. World In Vitro Transcription RNA Synthesis Service Market Size by RNA Length (2027-2032) & (USD Million)
Table 38. World In Vitro Transcription RNA Synthesis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World In Vitro Transcription RNA Synthesis Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World In Vitro Transcription RNA Synthesis Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Maravai LifeSciences Basic Information, Manufacturing Base and Competitors
Table 42. Maravai LifeSciences Major Business
Table 43. Maravai LifeSciences In Vitro Transcription RNA Synthesis Service Product and Services
Table 44. Maravai LifeSciences In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Maravai LifeSciences Recent Developments/Updates
Table 46. Maravai LifeSciences Competitive Strengths & Weaknesses
Table 47. Danaher Basic Information, Manufacturing Base and Competitors
Table 48. Danaher Major Business
Table 49. Danaher In Vitro Transcription RNA Synthesis Service Product and Services
Table 50. Danaher In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Danaher Recent Developments/Updates
Table 52. Danaher Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific In Vitro Transcription RNA Synthesis Service Product and Services
Table 56. Thermo Fisher Scientific In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. Lonza Basic Information, Manufacturing Base and Competitors
Table 60. Lonza Major Business
Table 61. Lonza In Vitro Transcription RNA Synthesis Service Product and Services
Table 62. Lonza In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Lonza Recent Developments/Updates
Table 64. Lonza Competitive Strengths & Weaknesses
Table 65. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 66. Merck KGaA Major Business
Table 67. Merck KGaA In Vitro Transcription RNA Synthesis Service Product and Services
Table 68. Merck KGaA In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Merck KGaA Recent Developments/Updates
Table 70. Merck KGaA Competitive Strengths & Weaknesses
Table 71. AGC Basic Information, Manufacturing Base and Competitors
Table 72. AGC Major Business
Table 73. AGC In Vitro Transcription RNA Synthesis Service Product and Services
Table 74. AGC In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. AGC Recent Developments/Updates
Table 76. AGC Competitive Strengths & Weaknesses
Table 77. Kaneka Basic Information, Manufacturing Base and Competitors
Table 78. Kaneka Major Business
Table 79. Kaneka In Vitro Transcription RNA Synthesis Service Product and Services
Table 80. Kaneka In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Kaneka Recent Developments/Updates
Table 82. Kaneka Competitive Strengths & Weaknesses
Table 83. Curia Basic Information, Manufacturing Base and Competitors
Table 84. Curia Major Business
Table 85. Curia In Vitro Transcription RNA Synthesis Service Product and Services
Table 86. Curia In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Curia Recent Developments/Updates
Table 88. Curia Competitive Strengths & Weaknesses
Table 89. Biomay Basic Information, Manufacturing Base and Competitors
Table 90. Biomay Major Business
Table 91. Biomay In Vitro Transcription RNA Synthesis Service Product and Services
Table 92. Biomay In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Biomay Recent Developments/Updates
Table 94. Biomay Competitive Strengths & Weaknesses
Table 95. GenScript Biotech Basic Information, Manufacturing Base and Competitors
Table 96. GenScript Biotech Major Business
Table 97. GenScript Biotech In Vitro Transcription RNA Synthesis Service Product and Services
Table 98. GenScript Biotech In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. GenScript Biotech Recent Developments/Updates
Table 100. GenScript Biotech Competitive Strengths & Weaknesses
Table 101. Hongene Biotech Basic Information, Manufacturing Base and Competitors
Table 102. Hongene Biotech Major Business
Table 103. Hongene Biotech In Vitro Transcription RNA Synthesis Service Product and Services
Table 104. Hongene Biotech In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Hongene Biotech Recent Developments/Updates
Table 106. Hongene Biotech Competitive Strengths & Weaknesses
Table 107. VectorBuilder Basic Information, Manufacturing Base and Competitors
Table 108. VectorBuilder Major Business
Table 109. VectorBuilder In Vitro Transcription RNA Synthesis Service Product and Services
Table 110. VectorBuilder In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. VectorBuilder Recent Developments/Updates
Table 112. VectorBuilder Competitive Strengths & Weaknesses
Table 113. Global Key Players of In Vitro Transcription RNA Synthesis Service Upstream (Raw Materials)
Table 114. Global In Vitro Transcription RNA Synthesis Service Typical Customers
Table 1. World In Vitro Transcription RNA Synthesis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World In Vitro Transcription RNA Synthesis Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World In Vitro Transcription RNA Synthesis Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World In Vitro Transcription RNA Synthesis Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World In Vitro Transcription RNA Synthesis Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World In Vitro Transcription RNA Synthesis Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World In Vitro Transcription RNA Synthesis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World In Vitro Transcription RNA Synthesis Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World In Vitro Transcription RNA Synthesis Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key In Vitro Transcription RNA Synthesis Service Players in 2025
Table 12. World In Vitro Transcription RNA Synthesis Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global In Vitro Transcription RNA Synthesis Service Company Evaluation Quadrant
Table 14. Head Office of Key In Vitro Transcription RNA Synthesis Service Players
Table 15. In Vitro Transcription RNA Synthesis Service Market: Company Product Type Footprint
Table 16. In Vitro Transcription RNA Synthesis Service Market: Company Product Application Footprint
Table 17. In Vitro Transcription RNA Synthesis Service Mergers & Acquisitions Activity
Table 18. United States VS China In Vitro Transcription RNA Synthesis Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China In Vitro Transcription RNA Synthesis Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based In Vitro Transcription RNA Synthesis Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies In Vitro Transcription RNA Synthesis Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies In Vitro Transcription RNA Synthesis Service Revenue Market Share (2021-2026)
Table 23. China Based In Vitro Transcription RNA Synthesis Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies In Vitro Transcription RNA Synthesis Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies In Vitro Transcription RNA Synthesis Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based In Vitro Transcription RNA Synthesis Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies In Vitro Transcription RNA Synthesis Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies In Vitro Transcription RNA Synthesis Service Revenue Market Share (2021-2026)
Table 29. World In Vitro Transcription RNA Synthesis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World In Vitro Transcription RNA Synthesis Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World In Vitro Transcription RNA Synthesis Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World In Vitro Transcription RNA Synthesis Service Market Size by Quality Grade, (USD Million), 2021 & 2025 & 2032
Table 33. World In Vitro Transcription RNA Synthesis Service Market Size Value by Quality Grade (2021-2026) & (USD Million)
Table 34. World In Vitro Transcription RNA Synthesis Service Market Size by Quality Grade (2027-2032) & (USD Million)
Table 35. World In Vitro Transcription RNA Synthesis Service Market Size by RNA Length, (USD Million), 2021 & 2025 & 2032
Table 36. World In Vitro Transcription RNA Synthesis Service Market Size Value by RNA Length (2021-2026) & (USD Million)
Table 37. World In Vitro Transcription RNA Synthesis Service Market Size by RNA Length (2027-2032) & (USD Million)
Table 38. World In Vitro Transcription RNA Synthesis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World In Vitro Transcription RNA Synthesis Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World In Vitro Transcription RNA Synthesis Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Maravai LifeSciences Basic Information, Manufacturing Base and Competitors
Table 42. Maravai LifeSciences Major Business
Table 43. Maravai LifeSciences In Vitro Transcription RNA Synthesis Service Product and Services
Table 44. Maravai LifeSciences In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Maravai LifeSciences Recent Developments/Updates
Table 46. Maravai LifeSciences Competitive Strengths & Weaknesses
Table 47. Danaher Basic Information, Manufacturing Base and Competitors
Table 48. Danaher Major Business
Table 49. Danaher In Vitro Transcription RNA Synthesis Service Product and Services
Table 50. Danaher In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Danaher Recent Developments/Updates
Table 52. Danaher Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific In Vitro Transcription RNA Synthesis Service Product and Services
Table 56. Thermo Fisher Scientific In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. Lonza Basic Information, Manufacturing Base and Competitors
Table 60. Lonza Major Business
Table 61. Lonza In Vitro Transcription RNA Synthesis Service Product and Services
Table 62. Lonza In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Lonza Recent Developments/Updates
Table 64. Lonza Competitive Strengths & Weaknesses
Table 65. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 66. Merck KGaA Major Business
Table 67. Merck KGaA In Vitro Transcription RNA Synthesis Service Product and Services
Table 68. Merck KGaA In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Merck KGaA Recent Developments/Updates
Table 70. Merck KGaA Competitive Strengths & Weaknesses
Table 71. AGC Basic Information, Manufacturing Base and Competitors
Table 72. AGC Major Business
Table 73. AGC In Vitro Transcription RNA Synthesis Service Product and Services
Table 74. AGC In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. AGC Recent Developments/Updates
Table 76. AGC Competitive Strengths & Weaknesses
Table 77. Kaneka Basic Information, Manufacturing Base and Competitors
Table 78. Kaneka Major Business
Table 79. Kaneka In Vitro Transcription RNA Synthesis Service Product and Services
Table 80. Kaneka In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Kaneka Recent Developments/Updates
Table 82. Kaneka Competitive Strengths & Weaknesses
Table 83. Curia Basic Information, Manufacturing Base and Competitors
Table 84. Curia Major Business
Table 85. Curia In Vitro Transcription RNA Synthesis Service Product and Services
Table 86. Curia In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Curia Recent Developments/Updates
Table 88. Curia Competitive Strengths & Weaknesses
Table 89. Biomay Basic Information, Manufacturing Base and Competitors
Table 90. Biomay Major Business
Table 91. Biomay In Vitro Transcription RNA Synthesis Service Product and Services
Table 92. Biomay In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Biomay Recent Developments/Updates
Table 94. Biomay Competitive Strengths & Weaknesses
Table 95. GenScript Biotech Basic Information, Manufacturing Base and Competitors
Table 96. GenScript Biotech Major Business
Table 97. GenScript Biotech In Vitro Transcription RNA Synthesis Service Product and Services
Table 98. GenScript Biotech In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. GenScript Biotech Recent Developments/Updates
Table 100. GenScript Biotech Competitive Strengths & Weaknesses
Table 101. Hongene Biotech Basic Information, Manufacturing Base and Competitors
Table 102. Hongene Biotech Major Business
Table 103. Hongene Biotech In Vitro Transcription RNA Synthesis Service Product and Services
Table 104. Hongene Biotech In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Hongene Biotech Recent Developments/Updates
Table 106. Hongene Biotech Competitive Strengths & Weaknesses
Table 107. VectorBuilder Basic Information, Manufacturing Base and Competitors
Table 108. VectorBuilder Major Business
Table 109. VectorBuilder In Vitro Transcription RNA Synthesis Service Product and Services
Table 110. VectorBuilder In Vitro Transcription RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. VectorBuilder Recent Developments/Updates
Table 112. VectorBuilder Competitive Strengths & Weaknesses
Table 113. Global Key Players of In Vitro Transcription RNA Synthesis Service Upstream (Raw Materials)
Table 114. Global In Vitro Transcription RNA Synthesis Service Typical Customers
LIST OF FIGURES
Figure 1. In Vitro Transcription RNA Synthesis Service Picture
Figure 2. World In Vitro Transcription RNA Synthesis Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World In Vitro Transcription RNA Synthesis Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World In Vitro Transcription RNA Synthesis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World In Vitro Transcription RNA Synthesis Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 13. In Vitro Transcription RNA Synthesis Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World In Vitro Transcription RNA Synthesis Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of In Vitro Transcription RNA Synthesis Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for In Vitro Transcription RNA Synthesis Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for In Vitro Transcription RNA Synthesis Service Markets in 2025
Figure 27. United States VS China: In Vitro Transcription RNA Synthesis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: In Vitro Transcription RNA Synthesis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World In Vitro Transcription RNA Synthesis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Type in 2025
Figure 31. Linear mRNA
Figure 32. Self-amplifying RNA
Figure 33. Circular RNA
Figure 34. Other
Figure 35. World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Type (2021-2032)
Figure 36. World In Vitro Transcription RNA Synthesis Service Market Size by Quality Grade, (USD Million), 2021 & 2025 & 2032
Figure 37. World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Quality Grade in 2025
Figure 38. Research Grade
Figure 39. GMP Grade
Figure 40. Other
Figure 41. World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Quality Grade (2021-2032)
Figure 42. World In Vitro Transcription RNA Synthesis Service Market Size by RNA Length, (USD Million), 2021 & 2025 & 2032
Figure 43. World In Vitro Transcription RNA Synthesis Service Market Size Market Share by RNA Length in 2025
Figure 44. Up to 1,000 nt
Figure 45. Above 1,000 nt to 5,000 nt
Figure 46. Above 5,000 nt to 10,000 nt
Figure 47. Above 10,000 nt
Figure 48. World In Vitro Transcription RNA Synthesis Service Market Size Market Share by RNA Length (2021-2032)
Figure 49. World In Vitro Transcription RNA Synthesis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Application in 2025
Figure 51. Pharmaceutical and Biotechnology Companies
Figure 52. Academic and Research Institutes
Figure 53. Other
Figure 54. World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Application (2021-2032)
Figure 55. In Vitro Transcription RNA Synthesis Service Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. In Vitro Transcription RNA Synthesis Service Picture
Figure 2. World In Vitro Transcription RNA Synthesis Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World In Vitro Transcription RNA Synthesis Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World In Vitro Transcription RNA Synthesis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World In Vitro Transcription RNA Synthesis Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company In Vitro Transcription RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 13. In Vitro Transcription RNA Synthesis Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World In Vitro Transcription RNA Synthesis Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India In Vitro Transcription RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of In Vitro Transcription RNA Synthesis Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for In Vitro Transcription RNA Synthesis Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for In Vitro Transcription RNA Synthesis Service Markets in 2025
Figure 27. United States VS China: In Vitro Transcription RNA Synthesis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: In Vitro Transcription RNA Synthesis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World In Vitro Transcription RNA Synthesis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Type in 2025
Figure 31. Linear mRNA
Figure 32. Self-amplifying RNA
Figure 33. Circular RNA
Figure 34. Other
Figure 35. World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Type (2021-2032)
Figure 36. World In Vitro Transcription RNA Synthesis Service Market Size by Quality Grade, (USD Million), 2021 & 2025 & 2032
Figure 37. World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Quality Grade in 2025
Figure 38. Research Grade
Figure 39. GMP Grade
Figure 40. Other
Figure 41. World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Quality Grade (2021-2032)
Figure 42. World In Vitro Transcription RNA Synthesis Service Market Size by RNA Length, (USD Million), 2021 & 2025 & 2032
Figure 43. World In Vitro Transcription RNA Synthesis Service Market Size Market Share by RNA Length in 2025
Figure 44. Up to 1,000 nt
Figure 45. Above 1,000 nt to 5,000 nt
Figure 46. Above 5,000 nt to 10,000 nt
Figure 47. Above 10,000 nt
Figure 48. World In Vitro Transcription RNA Synthesis Service Market Size Market Share by RNA Length (2021-2032)
Figure 49. World In Vitro Transcription RNA Synthesis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Application in 2025
Figure 51. Pharmaceutical and Biotechnology Companies
Figure 52. Academic and Research Institutes
Figure 53. Other
Figure 54. World In Vitro Transcription RNA Synthesis Service Market Size Market Share by Application (2021-2032)
Figure 55. In Vitro Transcription RNA Synthesis Service Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
